"Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia"

[JIDD]

Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia - news-medical.net/news/20221... - small USA trial (68) with acalabrutinib, obinutuzumab and venetoclax showed "At a median follow-up of 35 months, 83% of the high-risk patients had undetectable minimal residual disease (MRD) – no detectable CLL cells per 100,000 white blood cells – in their bone marrow. And 45% had the deepest measurable response to the treatment: complete remission and undetectable MRD in the bone marrow."

Source dana-farber.org/newsroom/ne...

[Thundercat2]

Such good news! I was offered a 3 drug trial with Obinutuzumab, Venetoclax and Pirobrutinib but declined it. I sort of wish I would have joined it now! But due to having a lot of side effects to Ibrutinib in an earlier trial with I +O, I decided I needed a break. I am on O+ V - finished my O treatments in July and am just on Venetoclax now. I will be tested for MRD in a couple of months, so fingers crossed that I have a good result. Thanks for posting this positive news!